Cost-effectiveness of stockpiling 23-valent pneumococcal polysaccharide vaccine to prevent secondary pneumococcal infections among a high-risk population in the united states during an influenza pandemic

✍ Scribed by Praveen Dhankhar; John D. Grabenstein; Megan A. O’Brien; Erik J. Dasbach

• Book ID: 113544274
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 278 KB
• Volume: 32
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2010.07.019